What's Hot
View all perspectives
TheDaoIndex KDAO2011
3 years 2 months ago
Dr. Furie thinks that pulse IV steroids are more effective than oral high dose steroids. If you use pulse IV, you can then use a lower oral dose of prednisone w/faster taper. Will he mandate pulse IV steroids w/his next trial? ...long pause.. No. #ACR21 @rheumnow
David Liew drdavidliew
3 years 2 months ago
CBD for pain in hand OA/inactive PsA:
- works in animal models (many things do)
- other neg RCTs didn't use CBD itself
- DBRCT: 12w continuous, n=136, min dropout
Result:
does absolutely nothing
I bet big money it will be tried again & again
@Joner_MD #ACR21 ABST1456 @RheumNow https://t.co/lZLVrgrKST
Richard Conway RichardPAConway
3 years 2 months ago
Dr Vela presents DB RCT on cannabidiol in hand OA and PsA. No effect seen. Abstr#1456 #ACR21 @RheumNow https://t.co/ck2eUx5Elz
Dr. John Cush RheumNow
3 years 2 months ago
The opening of #ACR21 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford).
Read more..
https://t.co/m98lrjFgS4 https://t.co/vKpCEDJiyx
Dr. John Cush RheumNow
3 years 2 months ago
COVID in Rheumatologic Disease Patients: Drs. Sparks, Liew, Yazdany and Dao provide an update on data specific to COVID in rheumatologic disease patients.
@jeffsparks @drdavidliew @KDAO2011
#ACR21
https://t.co/IzDIpe5IrU https://t.co/6i8C3Grw9q
David Liew drdavidliew
3 years 2 months ago
apart from that, fibrosis is fascinating - as is the potential for a shared fibrotic pathway
#ACR21 Antifibrotics session @RheumNow https://t.co/FXbhBx9sJ1
TheDaoIndex KDAO2011
3 years 2 months ago
@ericdeinmd Although the MTX/alopecia - nausea poster was interesting. Abst#1444 #ACR21
Factors assc w/MTX- nausea/alopecia:
👉female sex
👉EtOH use
👉higher disease activity
👉belief that the med will cause it
(older age assc w/⬇️risk of nausea) https://t.co/XDKFhvN0V1
@rheumnow
Eric Dein ericdeinmd
3 years 2 months ago
#ACR21 Ab#1445. RTX & #covid19 outcomes
⭐️RTX ass. w/ Upwards arrow COVID hospitalization, ICU admission, and ventilation
▶️We need huge caution in pts that have not been vax'ed before RTX 💉💉
@Rheumnow
https://t.co/6UNUVhnBkI https://t.co/vHkQe9fZpI
Eric Dein ericdeinmd
3 years 2 months ago
#ACR21 Ab#1036.
Rheum is often the field of uncertainty. @zach_wallace_md shows uncertainty correlates w/ depression, anxiety, sickness impact across rheum diseases
⭐️Is uncertainty something to target as intervention?
@Rheumnow https://t.co/v9kbk2hCqO https://t.co/50ELS3ZQp9
Janet Pope Janetbirdope
3 years 2 months ago
So what do we do with Iberdomide data? Tough to analyze re 2nd half of yr1 and uncertainty of dose response Abst#1458 #ACR21 @RheumNow v low placebo response 35% Interesting https://t.co/JXnoJTy2tv
swethaann23 swethaann23
3 years 2 months ago
Among 6 CV risk algorithms, the best to predict the carotid plaque (CP) in PsA is the ACC/AHA risk score showed an AUC 0.681 (0.551-0.812), p=0.008, a cut-off point ≥4.8, sensitivity of 63.6%, and specificity of 64.4%
⭐️Prevalence CP 42.3%
Abst #1315 #ACR21 @RheumNow https://t.co/hRvyjetYq3
Poster Hall